MR results showed evidence of a negative association between increased expression of TP53 and ER+ breast cancer risk (OR per SD increase in expression level: 0.77; 95% CI 0.66, 0.90; P = 0.001) using eQTLs obtained from blood. This evidence concerns the gene TP53 and breast cancer.